Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Cimarron Acquires Infusion Management

Posted in Healthcare Services Investing

Cimarron Healthcare Capital (CHC) has acquired Infusion Management, according to a news release.

Infusion Management, headquartered in Thousand Oaks, Calif., is an infusion therapy management services organization providing services to Infusion for Health, a provider of infusion treatment services to patients in the Los Angeles market.

Founded in 2014, CHC is a private equity firm focusing on healthcare investments in the lower middle market. Based in Salt Lake City, Utah, CHC targets companies with $5 million to $75 million in revenue and up to $15 million of EBITDA for $5 million to $25 million equity investments.

Financial terms of the transaction were not disclosed.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.